Decision Makers Roundtable - Health & Pharma
Health & Pharma Decision Makers Roundtable
From Breakthrough to Bedside: A Practical Roadmap for AI Innovation in Health & Pharma
📅 Thursday, May 21
🕘 9:30 AM – 12:00 PM (GMT+2)
📍 Merantix AI Campus, Max-Urich-Straße 3, Berlin
The promise of AI in healthcare and pharma is undeniable — yet many organizations remain stuck between pilots and real-world impact.
This exclusive roundtable brings together a curated group of decision-makers to explore a practical roadmap for AI innovation across the health and pharmaceutical value chain — from early research to clinical application and patient outcomes.
Together, we will discuss how to move beyond experimentation and unlock scalable, compliant, and value-driven AI solutions in a highly regulated environment.
What to expect:
A peer-level exchange on real-world AI adoption challenges and successes
Insights into scaling AI from pilots to production in GxP and clinical settings
Discussion on data readiness, interoperability, and infrastructure
Strategies for navigating compliance, governance, and organizational barriers
Concrete use cases across:
AI-driven diagnostics and medical imaging
Personalized treatment and patient pathways
Drug discovery and R&D acceleration
AI-powered documentation and knowledge systems
Who should attend:
Senior leaders and decision-makers from healthcare providers, pharma, biotech, and health-tech organizations (e.g., Digital, Data, Innovation, Medical, IT).
Why join:
Healthcare systems and pharma organizations face increasing pressure: rising costs, workforce shortages, and growing data complexity. AI has the potential to fundamentally reshape how care is delivered and how therapies are developed — but only if implemented effectively.
This roundtable is designed to provide practical perspectives, trusted exchange, and actionable insights to help you define your next steps in your AI journey.
About your host:
Bertram Weiss is VP Health at Merantix Momentum, where he drives AI-enabled transformation in the healthcare and life sciences sector. He brings more than 25 years of experience across pharmaceutical R&D, computational biology, and data science, with a strong focus on turning advanced analytics and AI into real-world impact across the drug discovery and healthcare value chain.
Throughout his career, he has led large-scale R&D and data science organizations, bridging the gap between scientific research, engineering, and business strategy. His work consistently focuses on translating complex biological and computational systems into actionable, value-driven solutions—combining deep domain expertise with a strong product and delivery mindset.
At Merantix Momentum, he plays a key role in shaping how AI is applied in regulated, high-impact environments, helping organizations move from experimentation to scalable, production-ready AI systems.
We look forward to welcoming you to a focused and high-quality discussion in a small, trusted group of peers.
Seats are limited.